(1058) Bridging Technology and Patient Care: Investigating the Role of Continuous Glucose Monitoring (CGM) in Influencing Health Perspectives of Those Living with Type II Diabetes

Objectives: IT IS BECOMING INCREASINGLY COMMON FOR INDIVIDUALS LIVING WITH TYPE 2 DIABETES WHO ARE NOT ON INSULIN TO UTILIZE CONTINUOUS GLUCOSE MONITORING (CGM). HOWEVER, REASONS FOR USING OR NOT USING CGM AMONG THESE PATIENTS HAVE NOT BEEN EXPLORED PREVIOUSLY. THEREFORE, THE OBJECTIVE OF THIS STUDY IS TO IDENTIFY AND COMPARE PATIENT PERSPECTIVES ON CGM USE, SPECIFICALLY THEIR PERCEIVED NORMS, ATTITUDES, BEHAVIORAL CONTROL, AND INTENTION TO USE CGM BETWEEN INDIVIDUALS WITH NON-INSULIN DEPENDENT DIABETES WHO CURRENTLY USE OR DO NOT USE CGM. THIS RESEARCH IS EXPECTED TO INFORM FUTURE INTERVENTIONS TO ENCOURAGE CGM USE AMONG NON-INSULIN DEPENDENT PERSONS LIVING WITH TYPE 2 DIABETES.

Methods: THIS STUDY IS A CROSS-SECTIONAL SURVEY GUIDED BY THE THEORY OF PLANNED BEHAVIOR (TPB). THE TPB IS A LEARNING THEORY THAT LINKS AN INDIVIDUALS’ ATTITUDES, SUBJECTIVE NORMS, PERCEIVED BEHAVIORAL CONTROL, AND INTENTIONS TO THEIR HEALTH BEHAVIORS. THE SURVEY CONSISTS OF 21 ITEMS, MAPPED TO THE TBP CONSTRUCTS. SPECIFICALLY, 19 ITEMS WILL MEASURE PATIENT PERSPECTIVES ON A LIKERT SCALE (E.G., 1= STRONGLY DISAGREE TO 5=STRONGLY AGREE). TWO ITEMS ARE OPEN RESPONSE QUESTIONS TO ENCOURAGE COMMENTS AND QUESTIONS FROM PATIENTS ABOUT PAST OR CURRENT INTEREST IN USING CGM. THE STUDY POPULATION WILL CONSIST OF INDIVIDUALS AT LEAST 18 YEARS OLD WHO HAVE FILLED A MEDICATION INDICATED FOR TYPE 2 DIABETES WITH THE EXCEPTION OF INSULIN OVER THE PAST 90 DAYS AT AN INDEPENDENTLY OWNED PHARMACY IN NEW ALBANY, INDIANA. INDIVIDUALS WHO MEET THE SURVEY INCLUSION CRITERIA WILL BE MAILED AN INVITATION LETTER WITH A QR CODE TO COMPLETE THE SURVEY ELECTRONICALLY. AFTER 14 DAYS, PATIENTS WILL BE CONTACTED BY TELEPHONE TO CONFIRM RECEIPT OF THE LETTER AND ELICIT ANY QUESTIONS. A REMINDER CALL WILL BE MADE TO ALL NON-RESPONDERS WITHIN 28 DAYS FOLLOWING THE INITIAL MAILING. ALL SURVEY DATA WILL BE COLLECTED IN REDCAP, AN ONLINE DATA COLLECTION SOFTWARE TOOL. CONSENT FOR PARTICIPATION WILL BE INDICATED BY RESPONDENTS IN REDCAP PRIOR TO TAKING THE SURVEY. INVESTIGATORS WILL COMPARE RESPONSES FROM CGM USERS TO NON-CGM USERS USING PAIRED T-TESTS. PRIOR TO COMMENCING DATA COLLECTION, THE SURVEY WILL BE PILOT TESTED WITH TWO PATIENTS FROM THE PHARMACY. THESE RESPONSES WILL BE OMITTED FROM THE FINAL ANALYSES. THIS RESEARCH STUDY IS CURRENTLY AWAITING IRB APPROVAL.

Results: Preliminary results will be presented at the APhA Annual Meeting.

Conclusions: CONCLUSIONS WILL BE PRESENTED AT THE APHA ANNUAL MEETING. OVERALL, THIS RESEARCH IS EXPECTED TO INFORM CONVERSATIONS BETWEEN HEALTHCARE PROFESSIONALS AND THEIR PATIENTS ABOUT CGM USE.